本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiora Pharmaceuticals

2.67
+0.07002.69%
盤後2.58-0.0900-3.37%16:24 EDT
成交量:2.00萬
成交額:5.33萬
市值:1,183.45萬
市盈率:-1.11
高:2.70
開:2.65
低:2.63
收:2.60
52周最高:2.95
52周最低:1.76
股本:443.24萬
流通股本:385.25萬
量比:1.07
換手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):-2.4100
每股收益(LYR):-2.6400
淨資產收益率:-56.36%
總資產收益率:-21.92%
市淨率:0.70
市盈率(LYR):-1.01

資料載入中...

2026/09/17

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/19

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

重要事件披露

Form 8-K - Current report
2026/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/05/21

SEC問詢函

Form CORRESP - Correspondence
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/25

重要事件披露

Form 8-K - Current report